{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:07:36Z","timestamp":1770624456209,"version":"3.49.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although anxiety is perhaps one of the most significant current medical and social problems, the neurochemical mechanistic background of this common condition remains to be fully understood. Multifunctional regulatory gasotransmitters are novel, atypical inorganic factors of the brain that are involved in the mechanisms of anxiety responses. Nitric oxide (NO) signaling shows ambiguous action in animal models of anxiety, while NO donors exert anxiogenic or anxiolytic effect depending on their chemical structure, dose, treatment schedule and gas release rapidity. The majority of NO synthase inhibitors act as a relatively potent axiolytic agents, while hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) and carbon monoxide (CO) delivered experimentally in the form of \u201cslow\u201d or \u201cfast\u201d releasing donors have recently been considered as anxiolytic neurotransmitters. In this comprehensive review we critically summarize the literature regarding the intriguing roles of NO, H<jats:sub>2<\/jats:sub>S and CO in the neuromolecular mechanisms of anxiety in the context of their putative, yet promising therapeutic application. A possible mechanism of gasotransmitter action at the level of anxiety-related synaptic transmission is also presented. Brain gasesous neuromediators urgently require further wide ranging studies to clarify their potential value for the current neuropharmacology of anxiety disorders.<\/jats:p>","DOI":"10.1007\/s43440-021-00242-2","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T10:02:27Z","timestamp":1615629747000},"page":"357-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The role of brain gaseous neurotransmitters in anxiety"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-1211","authenticated-orcid":false,"given":"Artur","family":"Pa\u0142asz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-9255","authenticated-orcid":false,"given":"Itiana Castro","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-5669","authenticated-orcid":false,"given":"John J.","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"242_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.31887\/DCNS.2017.19.2\/dstein","volume":"19","author":"DJ Stein","year":"2017","unstructured":"Stein DJ, Scott KM, de Jonge P. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017;19:127\u201336. https:\/\/doi.org\/10.31887\/DCNS.2017.19.2\/dstein.","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"242_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/mp.2011.88","volume":"17","author":"B Myers-Schulz","year":"2012","unstructured":"Myers-Schulz B, Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry. 2012;17(2):132\u201341. https:\/\/doi.org\/10.1038\/mp.2011.88.","journal-title":"Mol Psychiatry"},{"issue":"Suppl 22","key":"242_CR3","first-page":"12","volume":"60","author":"PT Ninan","year":"1999","unstructured":"Ninan PT. The functional anatomy, neurochemistry, and pharmacology of anxiety. J Clin Psychiatry. 1999;60(Suppl 22):12\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"242_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.13040\/IJPSR.0975-8232.8(2)","volume":"8","author":"S Kaur","year":"2017","unstructured":"Kaur S, Singh R. Role of different neurotransmitters in anxiety: a systemic review. Int J Pharm Sci Res. 2017;8(2):411\u201321. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.8(2).","journal-title":"Int J Pharm Sci Res"},{"issue":"3","key":"242_CR5","first-page":"21","volume":"64","author":"RB Lydiard","year":"2003","unstructured":"Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry. 2003;64(3):21\u20137.","journal-title":"J Clin Psychiatry"},{"key":"242_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1744-9081-8-61","volume":"8","author":"GM Carta","year":"2012","unstructured":"Carta GM, Bhat MK, Preti MK. GABAergic neuroactive steroids: a new frontier in bipolar disorders? Behav Brain Funct. 2012;8:61. https:\/\/doi.org\/10.1186\/1744-9081-8-61.","journal-title":"Behav Brain Funct"},{"issue":"2","key":"242_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12031-019-01307-x","volume":"68","author":"K Bogus","year":"2019","unstructured":"Bogus K, Pa\u0142asz A, Suszka-\u015awitek A, Worthington JJ, Krzystanek M, Wiaderkiewicz R. Chronic antipsychotic treatment modulates aromatase (CYP19A1) expression in the male rat brain. J Mol Neurosci. 2019;68(2):311\u20137. https:\/\/doi.org\/10.1007\/s12031-019-01307-x.","journal-title":"J Mol Neurosci"},{"key":"242_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","volume":"14","author":"V Bergink","year":"2004","unstructured":"Bergink V, van Megen HJ, Westenberg HG. Glutamate and anxiety. Eur Neuropsychopharmacol. 2004;14:175\u201383. https:\/\/doi.org\/10.1016\/S0924-977X(03)00100-7.","journal-title":"Eur Neuropsychopharmacol"},{"key":"242_CR9","first-page":"941","volume":"73","author":"A Garakani","year":"2006","unstructured":"Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med. 2006;73:941\u20139.","journal-title":"Mt Sinai J Med"},{"key":"242_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0014-2999(03)01275-5","volume":"463","author":"MJ Millan","year":"2003","unstructured":"Millan MJ, Brocco M. The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines. Eur J Pharmacol. 2003;463:67\u201396. https:\/\/doi.org\/10.1016\/s0014-2999(03)01275-5.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"242_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","volume":"66","author":"E Akimova","year":"2009","unstructured":"Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biol Psychiatry. 2009;66(7):627\u201335. https:\/\/doi.org\/10.1016\/j.biopsych.2009.03.012.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"242_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/archneurosci.18555","volume":"2","author":"M Jia","year":"2014","unstructured":"Jia M, Pittman J. Deficits in striatal dopamine and hippocampal serotonin following induction of anxiety\/depressive like behaviors by bisphenol A. Arch Neurosci. 2014;2(2):1\u20136. https:\/\/doi.org\/10.5812\/archneurosci.18555.","journal-title":"Arch Neurosci"},{"key":"242_CR13","doi-asserted-by":"publisher","first-page":"20120435","DOI":"10.1098\/rstb.2012.0435","volume":"368","author":"DL Murphy","year":"2013","unstructured":"Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive\u2013 compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philos Trans R Soc B. 2013;368:20120435. https:\/\/doi.org\/10.1098\/rstb.2012.0435.","journal-title":"Philos Trans R Soc B"},{"key":"242_CR14","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1073\/pnas.0505407103","volume":"103","author":"Q Chen","year":"2006","unstructured":"Chen Q, Nakajima A, Meacham C, Tang YP. Elevated cholecystokininergic tone constitutes an important molecular\/neuronal mechanism for the expression of anxiety in the mouse. Proc Natl Acad Sci. 2006;103:3881\u20136. https:\/\/doi.org\/10.1073\/pnas.0505407103.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"242_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00441-018-2902-2","volume":"375","author":"T Grund","year":"2019","unstructured":"Grund T, Neumann ID. Brain neuropeptide S: via GPCR activation to a powerful neuromodulator of socio-emotional behaviors. Cell Tissue Res. 2019;375(1):123\u201332. https:\/\/doi.org\/10.1007\/s00441-018-2902-2.","journal-title":"Cell Tissue Res"},{"key":"242_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuint.2017.12.006","volume":"113","author":"A Pa\u0142asz","year":"2018","unstructured":"Pa\u0142asz A, Janas-Kozik M, Borrow A, Arias-Carri\u00f3n O, Worthington JJ. The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa. Neurochem Int. 2018;113:120\u201336. https:\/\/doi.org\/10.1016\/j.neuint.2017.12.006.","journal-title":"Neurochem Int"},{"issue":"3","key":"242_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1742-7843.2011.00710.x","volume":"109","author":"C Maximino","year":"2011","unstructured":"Maximino C, Lima MG, Olivera KR, Pican\u00e7o-Diniz DL, Herculano AM. Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish. Basic Clin Pharmacol Toxicol. 2011;109(3):203\u20137. https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00710.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"242_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-801028-0.00103-3","author":"JA Donald","year":"2016","unstructured":"Donald JA. Gasotransmitter family. Handb Horm. 2016. https:\/\/doi.org\/10.1016\/b978-0-12-801028-0.00103-3.","journal-title":"Handb Horm"},{"key":"242_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.resp.2012.03.016","volume":"184","author":"M Kajimura","year":"2012","unstructured":"Kajimura M, Nakanishi T, Takenouchi T, Morikawa T, Hishiki T, Yukutake Y, et al. Gas biology: tiny molecules controlling metabolic systems. Respir Physiol Neurobiol. 2012;184:139\u201348. https:\/\/doi.org\/10.1016\/j.resp.2012.03.016.","journal-title":"Respir Physiol Neurobiol"},{"key":"242_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.niox.2020.07.002","volume":"103","author":"Y Wang","year":"2020","unstructured":"Wang Y, Yu R, Wu L, Yang G. Hydrogen sulfide signaling in regulation of cell behaviors. Nitric Oxide. 2020;103:9\u201319. https:\/\/doi.org\/10.1016\/j.niox.2020.07.002.","journal-title":"Nitric Oxide"},{"key":"242_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/bse0330079","volume":"33","author":"JE Haley","year":"1998","unstructured":"Haley JE. Gases as neurotransmitters. Essays Biochem. 1998;33:79\u201391. https:\/\/doi.org\/10.1042\/bse0330079.","journal-title":"Essays Biochem"},{"key":"242_CR22","volume-title":"Gasotransmitters: physiology and pathophysiology","author":"AA Untereiner","year":"2012","unstructured":"Untereiner AA, Wu L, Wang R. The role of carbon monoxide as a gasotransmitter in cardiovascular and metabolic regulation. In: Hermann A, Sitdikova G, Weiger T, editors. Gasotransmitters: physiology and pathophysiology. Berlin: Springer; 2012."},{"key":"242_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.57.4.3","volume":"57","author":"L Wu","year":"2005","unstructured":"Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005;57:585\u2013630. https:\/\/doi.org\/10.1124\/pr.57.4.3.","journal-title":"Pharmacol Rev"},{"key":"242_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrd3228","volume":"9","author":"R Motterlini","year":"2010","unstructured":"Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9:728\u201343. https:\/\/doi.org\/10.1038\/nrd3228.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"242_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nm0498-460","volume":"4","author":"V Jevtovi\u0107-Todorovi\u0107","year":"1998","unstructured":"Jevtovi\u0107-Todorovi\u0107 V, Todorovi\u0107 SM, Mennerick S, Powell S, Dikranian K, Benshoff N, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4(4):460\u20133. https:\/\/doi.org\/10.1038\/nm0498-460.","journal-title":"Nat Med"},{"key":"242_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00000539-199504000-00003","volume":"80","author":"AD Finck","year":"1995","unstructured":"Finck AD, Samaniego E, Ngai SH. Nitrous oxide selectively releases met5-enkephalin and met5-enkephalin-arg6-phe7 into canine third ventricular cerebrospinal fluid. Anesth Analg. 1995;80:664\u201370. https:\/\/doi.org\/10.1097\/00000539-199504000-00003.","journal-title":"Anesth Analg"},{"key":"242_CR27","doi-asserted-by":"publisher","first-page":"8961951","DOI":"10.1155\/2016\/8961951","volume":"2016","author":"Y Huang","year":"2016","unstructured":"Huang Y, Tang C, Du J, Jin H. Endogenous sulfur dioxide: a new member of gasotransmitter family in the cardiovascular system. Oxid Med Cell Longev. 2016;2016:8961951. https:\/\/doi.org\/10.1155\/2016\/8961951.","journal-title":"Oxid Med Cell Longev"},{"issue":"13","key":"242_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/WNR.000000000000130","volume":"30","author":"B Li","year":"2019","unstructured":"Li B, Gao MX, Yang WL, Chai C, Zhang DX, Cai HY, et al. Inhibitory effects of sulfur dioxide within the nucleus tractus solitarii of rats: involvement of calcium ion channels, adenine nucleoside triphosphate-sensitive potassium channels, and the nitric oxide\/cyclic guanine trinucleotide phosphate pathway. NeuroReport. 2019;30(13):914\u201320. https:\/\/doi.org\/10.1097\/WNR.000000000000130.","journal-title":"NeuroReport"},{"key":"242_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1749-6632.2003.tb07204.x","volume":"986","author":"R Stimac","year":"2003","unstructured":"Stimac R, Kerek F, Apell HJ. Macrocyclic carbon suboxide oligomers as potent inhibitors of the Na,K-ATPase. Ann N Y Acad Sci. 2003;986:327\u20139. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07204.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"242_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0005-2736(02)00609-0","volume":"1567","author":"F Kerek","year":"2002","unstructured":"Kerek F, Stimac R, Apell HJ, Freudenmann F, Moroder L. Characterization of the macrocyclic carbon suboxide factors as potent Na, K-ATPase and SR Ca-ATPase inhibitors. Biochim Biophys Acta Biomembr. 2002;1567(1\u20132):213\u201320. https:\/\/doi.org\/10.1016\/S0005-2736(02)00609-0.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1\u20132","key":"242_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0006-8993(97)00659-8","volume":"768","author":"JL Borowitz","year":"1997","unstructured":"Borowitz JL, Gunasekar PG, Isom GE. Hydrogen cyanide generation by mu-opiate receptor activation: possible neuromodulatory role of endogenous cyanide. Brain Res. 1997;768(1\u20132):294\u2013300. https:\/\/doi.org\/10.1016\/S0006-8993(97)00659-8.","journal-title":"Brain Res"},{"issue":"Suppl 6","key":"242_CR32","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1016\/s0924-977x(99)00052-8","volume":"9","author":"SV Argyropoulos","year":"1999","unstructured":"Argyropoulos SV, Nutt DJ. The use of benzodiazepines in anxiety and other disorders. Eur Neuropsychopharmacol. 1999;9(Suppl 6):S407-412. https:\/\/doi.org\/10.1016\/s0924-977x(99)00052-8.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"242_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/16506073.2018.1560358","volume":"49","author":"E Carl","year":"2020","unstructured":"Carl E, Witcraft SM, Kauffman BY, Gillespie EM, Becker ES, Cuijpers P, et al. Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials. Cogn Behav Ther. 2020;49(1):1\u201321. https:\/\/doi.org\/10.1080\/16506073.2018.1560358.","journal-title":"Cogn Behav Ther"},{"issue":"2","key":"242_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.31887\/DCNS.2017.19.2\/fthibaut","volume":"19","author":"F Thibaut","year":"2017","unstructured":"Thibaut F. Anxiety disorders: a review of current literature. Dialogues Clin Neurosci. 2017;19(2):87\u20138. https:\/\/doi.org\/10.31887\/DCNS.2017.19.2\/fthibaut.","journal-title":"Dialogues Clin Neurosci"},{"issue":"11","key":"242_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.mp.4001779","volume":"2006","author":"A Reif","year":"2006","unstructured":"Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry. 2006;2006(11):286\u2013300. https:\/\/doi.org\/10.1038\/sj.mp.4001779.","journal-title":"Mol Psychiatry"},{"key":"242_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archgenpsychiatry.2008.510","volume":"66","author":"A Reif","year":"2009","unstructured":"Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry. 2009;66:41\u201350. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2008.510.","journal-title":"Arch Gen Psychiatry"},{"key":"242_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ph3010273","volume":"3","author":"G Wegener","year":"2010","unstructured":"Wegener G, Volke V. Nitric oxide synthase inhibitors as antidepressants. Pharmaceuticals (Basel). 2010;3:273\u201399. https:\/\/doi.org\/10.3390\/ph3010273.","journal-title":"Pharmaceuticals (Basel)"},{"key":"242_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.niox.2018.04.002","volume":"77","author":"N Pitsikas","year":"2018","unstructured":"Pitsikas N. The role of nitric oxide (NO) donors in anxiety. Lights and shadows. Nitric Oxide. 2018;77:6\u201311. https:\/\/doi.org\/10.1016\/j.niox.2018.04.002.","journal-title":"Nitric Oxide"},{"key":"242_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.euroneuro.2017.09.004","volume":"30","author":"H Carre\u00f1o-Guti\u00e9rrez","year":"2020","unstructured":"Carre\u00f1o-Guti\u00e9rrez H, O\u2019Leary A, Freudenberg F, Fedele G, Wilkinson R, Markham E, et al. Nitric oxide interacts with monoamine oxidase to modulate aggression and anxiety-like behavior. Eur Neuropsychopharmacol. 2020;30:30\u201343. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.09.004.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"24","key":"242_CR40","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2174\/0929867323666160627120408","volume":"23","author":"A Philippu","year":"2016","unstructured":"Philippu A. Nitric oxide: a universal modulator of brain function. Curr Med Chem. 2016;23(24):2643\u201352. https:\/\/doi.org\/10.2174\/0929867323666160627120408.","journal-title":"Curr Med Chem"},{"issue":"16","key":"242_CR41","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1111\/bph.15084","volume":"177","author":"LJ Zhu","year":"2020","unstructured":"Zhu LJ, Shi HJ, Chang L, Zhang CC, Si M, Li N, et al. nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety. Br J Pharmacol. 2020;177(16):3674\u201390. https:\/\/doi.org\/10.1111\/bph.15084.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"242_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/ars.2016.6693","volume":"26","author":"WR Montfort","year":"2017","unstructured":"Montfort WR, Wales JA, Weichsel A. Structure and activation of soluble guanylyl cyclase, the nitric oxide sensor. Antioxid Redox Signal. 2017;26(3):107\u201321. https:\/\/doi.org\/10.1089\/ars.2016.6693.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"242_CR43","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","volume":"1865","author":"P Pic\u00f3n-Pag\u00e8s","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s P, Garcia-Buendia J, Mu\u00f1oz FJ. Functions and dysfunctions of nitric oxide in brain. Biochim Biophys Acta Mol Basis Dis. 2019;1865(8):1949\u201367. https:\/\/doi.org\/10.1016\/j.bbadis.2018.11.007.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"242_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neubiorev.2006.11.001","volume":"31","author":"TM Edwards","year":"2007","unstructured":"Edwards TM, Rickard NS. New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes. Neurosci Biobehav Rev. 2007;31:413\u201325. https:\/\/doi.org\/10.1016\/j.neubiorev.2006.11.001.","journal-title":"Neurosci Biobehav Rev"},{"key":"242_CR45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/bph.12217","volume":"169","author":"TA Heinrich","year":"2013","unstructured":"Heinrich TA, Da Silva RS, Miranda KM, Switzer CH, Wink DA, Fukuto JM. Biological nitric oxide signaling: chemistry and terminology. Br J Pharmacol. 2013;169:1417\u201329. https:\/\/doi.org\/10.1111\/bph.12217.","journal-title":"Br J Pharmacol"},{"key":"242_CR46","doi-asserted-by":"publisher","first-page":"135083","DOI":"10.1016\/j.neulet.2020.135083","volume":"734","author":"Y Tomiga","year":"2020","unstructured":"Tomiga Y, Sakai K, Nakashima S, Uehara Y, Kawanaka K, Higaki Y. Effects of inosine monophosphate and exercise training on neuronal nitric oxide synthase in the mouse brain. Neurosci Lett. 2020;734:135083. https:\/\/doi.org\/10.1016\/j.neulet.2020.135083.","journal-title":"Neurosci Lett"},{"key":"242_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0006-291x(88)80015-9","volume":"157","author":"JB Hibbs Jr","year":"1988","unstructured":"Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87\u201394. https:\/\/doi.org\/10.1016\/s0006-291x(88)80015-9.","journal-title":"Biochem Biophys Res Commun"},{"key":"242_CR48","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrn2214","volume":"8","author":"V Calabrese","year":"2007","unstructured":"Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci. 2007;8:766\u201375. https:\/\/doi.org\/10.1038\/nrn2214.","journal-title":"Nat Rev Neurosci"},{"key":"242_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.niox.2018.02.004","volume":"75","author":"JC Mart\u00ednez-Lazcano","year":"2018","unstructured":"Mart\u00ednez-Lazcano JC, Gonz\u00e1lez-Guevara E, Custodio V, P\u00e9rez-Severiano F, Olvera-P\u00e9rez K, Salgado-Mozo S, et al. Activity of nitric oxide synthase isoforms in acute brain oxidative damage induced by ozone exposure. Nitric Oxide. 2018;75:42\u201352. https:\/\/doi.org\/10.1016\/j.niox.2018.02.004.","journal-title":"Nitric Oxide"},{"issue":"S4","key":"242_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1289\/ehp.01109s4539","volume":"109","author":"WP Watkinson","year":"2001","unstructured":"Watkinson WP, Campen MJ, Nolan JP, Costa DL. Cardiovascular and systemic responses to inhaled pollutants in rodents: effects of ozone and particulate matter. Environ Health Perspect. 2001;109(S4):539\u201346. https:\/\/doi.org\/10.1289\/ehp.01109s4539.","journal-title":"Environ Health Perspect"},{"key":"242_CR51","doi-asserted-by":"publisher","first-page":"102268","DOI":"10.1016\/j.nicl.2020.102268","volume":"27","author":"IC Ridderbusch","year":"2020","unstructured":"Ridderbusch IC, Yang Y, Weber H, Reif A, Herterich S, Str\u00f6hle A, et al. Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI. Neuroimage Clin. 2020;27:102268. https:\/\/doi.org\/10.1016\/j.nicl.2020.102268.","journal-title":"Neuroimage Clin"},{"issue":"2\u20133","key":"242_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0005-2728(99)00020-1","volume":"1411","author":"M Kelm","year":"1999","unstructured":"Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta. 1999;1411(2\u20133):273\u201389. https:\/\/doi.org\/10.1016\/s0005-2728(99)00020-1.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"242_CR53","first-page":"942","volume":"120","author":"BR Buca","year":"2016","unstructured":"Buca BR, Mititelu-Tar\u0163au L, Lupu\u015foru RV, Popa GE, Rezu\u015f C, Lupu\u015foru CE. New nitric oxide donors with therapeutic potential. Rev Med Chir Soc Med Nat Iasi. 2016;120(4):942\u20136.","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"3","key":"242_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/1389557516666160808124624","volume":"17","author":"AB Seabra","year":"2017","unstructured":"Seabra AB, Duran N. Nanoparticulated nitric oxide donors and their biomedical applications. Mini Rev Med Chem. 2017;17(3):216\u201323. https:\/\/doi.org\/10.2174\/1389557516666160808124624.","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"242_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/1028415031000079685","volume":"6","author":"M Smriga","year":"2003","unstructured":"Smriga M, Torii K. Prolonged treatment with l-lysine and l-arginine reduces stress-induced anxiety in an elevated plus maze. Nutr Neurosci. 2003;6(2):125\u20138. https:\/\/doi.org\/10.1080\/1028415031000079685.","journal-title":"Nutr Neurosci"},{"issue":"5","key":"242_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/10284150310001614661","volume":"6","author":"S Srinongkote","year":"2003","unstructured":"Srinongkote S, Smriga M, Nakagawa K, Toride Y. A diet fortified with l-lysine and l-arginine reduces plasma cortisol and blocks anxiogenic response to transportation in pigs. Nutr Neurosci. 2003;6(5):283\u20139. https:\/\/doi.org\/10.1080\/10284150310001614661.","journal-title":"Nutr Neurosci"},{"issue":"2","key":"242_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2220\/biomedres.28.85","volume":"28","author":"M Smriga","year":"2007","unstructured":"Smriga M, Ando T, Akutsu M, Furukawa Y, Miwa K, Morinaga Y. Oral treatment with l-lysine and l-arginine reduces anxiety and basal cortisol levels in healthy humans. Biomed Res. 2007;28(2):85\u201390. https:\/\/doi.org\/10.2220\/biomedres.28.85.","journal-title":"Biomed Res"},{"issue":"3","key":"242_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10284150500162937","volume":"8","author":"D Jezova","year":"2005","unstructured":"Jezova D, Makatsori A, Smriga M, Morinaga Y, Duncko R. Subchronic treatment with amino acid mixture of l-lysine and l-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety. Nutr Neurosci. 2005;8(3):155\u201360. https:\/\/doi.org\/10.1080\/10284150500162937.","journal-title":"Nutr Neurosci"},{"issue":"4","key":"242_CR59","first-page":"653","volume":"54","author":"V Volke","year":"2003","unstructured":"Volke V, Wegener G, Vasar E. Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Physiol Pharmacol. 2003;54(4):653\u201360.","journal-title":"J Physiol Pharmacol"},{"key":"242_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yhbeh.2016.01.002","volume":"79","author":"MP Faria","year":"2016","unstructured":"Faria MP, Miguel TT, Gomes KS, Nunes-de-Souza RL. Anxiety-like responses induced by nitric oxide within the BNST in mice: role of CRF1 and NMDA receptors. Horm Behav. 2016;79:74\u201383. https:\/\/doi.org\/10.1016\/j.yhbeh.2016.01.002.","journal-title":"Horm Behav"},{"key":"242_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2016.04.011","volume":"108","author":"NS Costa","year":"2016","unstructured":"Costa NS, Vicente MA, Cipriano AC, Miguel TT, Nunes-de-Souza RL. Functional lateralization of the medial prefrontal cortex in the modulation of anxiety in mice: left or right? Neuropharmacology. 2016;108:82\u201390. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.011.","journal-title":"Neuropharmacology"},{"key":"242_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pbb.2015.09.004","volume":"138","author":"T Kalouda","year":"2015","unstructured":"Kalouda T, Pitsikas N. The nitric oxide donor molsidomine induces anxiolytic-like behavior in two different rat models of anxiety. Pharmacol Biochem Behav. 2015;138:111\u20136. https:\/\/doi.org\/10.1016\/j.pbb.2015.09.004.","journal-title":"Pharmacol Biochem Behav"},{"key":"242_CR63","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/s0091-3057(01)00487-7","volume":"68","author":"S Li","year":"2001","unstructured":"Li S, Quock RM. Comparison of N2O\u2212 and chlordiazepoxide-induced behaviors in the light\/dark exploration test. Pharmacol Biochem Behav. 2001;68:789\u201396. https:\/\/doi.org\/10.1016\/s0091-3057(01)00487-7.","journal-title":"Pharmacol Biochem Behav"},{"key":"242_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.niox.2017.05.002","volume":"69","author":"MA Orfanidou","year":"2017","unstructured":"Orfanidou MA, Lafioniatis A, Trevlopoulou A, Touzlatzi N, Pitsikas N. Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety. Nitric Oxide. 2017;69:56\u201360. https:\/\/doi.org\/10.1016\/j.niox.2017.05.002.","journal-title":"Nitric Oxide"},{"key":"242_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2020.03.005","volume":"99","author":"A Papageorgoulis","year":"2020","unstructured":"Papageorgoulis A, Fallon P, Mpalantes N, Papageorgouli D, Pitsikas N. Repeated but not acute exposure with a low dose range of the nitric oxide (NO) donor sodium nitroprusside (SNP) induces anxiolytic-like behavior in a dose-independent manner in two different rat models of anxiety. Nitric Oxide. 2020;99:1\u20136. https:\/\/doi.org\/10.1016\/j.niox.2020.03.005.","journal-title":"Nitric Oxide"},{"key":"242_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.niox.2009.07.001","volume":"21","author":"SN Umathe","year":"2009","unstructured":"Umathe SN, Bhutada PS, Jain S, Munhada YR, Borkar SS, Dhumal B. Role of nitric oxide in obsessive\u2013compulsive behavior and its involvement in the anticompulsive effect of paroxetine in mice. Nitric Oxide. 2009;21:140\u20137. https:\/\/doi.org\/10.1016\/j.niox.2009.07.001.","journal-title":"Nitric Oxide"},{"issue":"4","key":"242_CR67","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1046\/j.1471-4159.2000.0751664.x","volume":"75","author":"L Trabace","year":"2000","unstructured":"Trabace L, Kendrick KM. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem. 2000;75(4):1664\u201374. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0751664.x.","journal-title":"J Neurochem"},{"issue":"8","key":"242_CR68","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.neubiorev.2005.03.026","volume":"29","author":"FS Guimar\u00e3es","year":"2005","unstructured":"Guimar\u00e3es FS, Beijamini V, Moreira FA, Aguiar DC, de Lucca AC. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev. 2005;29(8):1313\u201322. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.026.","journal-title":"Neurosci Biobehav Rev"},{"key":"242_CR69","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0166-4328(02)00084-0","volume":"134","author":"IL Heiberg","year":"2002","unstructured":"Heiberg IL, Wegener G, Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res. 2002;134:479\u201384. https:\/\/doi.org\/10.1016\/s0166-4328(02)00084-0.","journal-title":"Behav Brain Res"},{"key":"242_CR70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","volume":"165","author":"MP Kaster","year":"2005","unstructured":"Kaster MP, Ferreira PK, Santos AR, Rodrigues AL. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res. 2005;165:204\u201349. https:\/\/doi.org\/10.1016\/j.bbr.2005.06.031.","journal-title":"Behav Brain Res"},{"key":"242_CR71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phytochem.2017.12.010","volume":"75","author":"F Liu","year":"2017","unstructured":"Liu F, Yang X, Ma J, Yang Y, Xie C, Tuerhong M, et al. Nitric oxide inhibitory daphnane diterpenoids as potential anti-neuroinflammatory agents for AD from the twigs of Trigonostemon thyrsoideus. Bioorg Chem. 2017;75:149\u201356. https:\/\/doi.org\/10.1016\/j.phytochem.2017.12.010.","journal-title":"Bioorg Chem"},{"key":"242_CR72","first-page":"587","volume":"53","author":"B Karolewicz","year":"2001","unstructured":"Karolewicz B, Paul IA, Antkiewicz-Michaluk L. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol J Pharmacol. 2001;53:587\u201396.","journal-title":"Pol J Pharmacol"},{"key":"242_CR73","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1523\/JNEUROSCI.5880-09.2010","volume":"30","author":"J Zhang","year":"2010","unstructured":"Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, et al. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors. J Neurosci. 2010;30:2433\u201341. https:\/\/doi.org\/10.1523\/JNEUROSCI.5880-09.2010.","journal-title":"J Neurosci"},{"key":"242_CR74","doi-asserted-by":"publisher","first-page":"112720","DOI":"10.1016\/j.bbr.2020.112720","volume":"392","author":"F Beheshti","year":"2020","unstructured":"Beheshti F, Hashemzehi M, Hosseini M, Marefati N, Memarpour S. Inducible nitric oxide synthase plays a role in depression- and anxiety-like behaviors chronically induced by lipopolysaccharide in rats: evidence from inflammationand oxidative stress. Behav Brain Res. 2020;392:112720. https:\/\/doi.org\/10.1016\/j.bbr.2020.112720.","journal-title":"Behav Brain Res"},{"key":"242_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000026338","volume":"5","author":"C Rivier","year":"1998","unstructured":"Rivier C. Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and nonimmune signals. NeuroImmunoModulation. 1998;5:203\u201313. https:\/\/doi.org\/10.1159\/000026338.","journal-title":"NeuroImmunoModulation"},{"key":"242_CR76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1365-2826.1998.00266.x","volume":"10","author":"AV Turnbull","year":"1998","unstructured":"Turnbull AV, Kim CK, Lee S, Rivier CL. Influence of carbon monoxide, and its interaction with nitric oxide, on the adrenocorticotropin hormone response of the normal rat to a physico-emotional stress. J Neuroendocrinol. 1998;10:793\u2013802. https:\/\/doi.org\/10.1046\/j.1365-2826.1998.00266.x.","journal-title":"J Neuroendocrinol"},{"key":"242_CR77","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1210\/endo.141.6.7500","volume":"141","author":"CK Kim","year":"2000","unstructured":"Kim CK, Rivier CL. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology. 2000;141:2244\u201353. https:\/\/doi.org\/10.1210\/endo.141.6.7500.","journal-title":"Endocrinology"},{"issue":"4","key":"242_CR78","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s0091-3057(03)00149-7","volume":"75","author":"DA Czech","year":"2003","unstructured":"Czech DA, Jacobson EB, LeSueur-Reed KT, Kazel MR. Putative anxiety-linked effects of the nitric oxide synthase inhibitor l-NAME in three murine exploratory behavior models. Pharmacol Biochem Behav. 2003;75(4):741\u20138. https:\/\/doi.org\/10.1016\/s0091-3057(03)00149-7.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"242_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1358\/mf.2006.28.2.977840","volume":"28","author":"S Sevgi","year":"2006","unstructured":"Sevgi S, Ozek M, Eroglu L. l-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol. 2006;28(2):95\u20139. https:\/\/doi.org\/10.1358\/mf.2006.28.2.977840.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"2","key":"242_CR80","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00213-005-0270-6","volume":"184","author":"D Forestiero","year":"2006","unstructured":"Forestiero D, Manfrim CM, Guimar\u00e3es FS, de Oliveira RM. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology. 2006;184(2):166\u201372. https:\/\/doi.org\/10.1007\/s00213-005-0270-6.","journal-title":"Psychopharmacology"},{"issue":"4","key":"242_CR81","first-page":"365","volume":"48","author":"N Gilhotra","year":"2010","unstructured":"Gilhotra N, Jain H, Dhingra D. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice. Indian J Exp Biol. 2010;48(4):365\u201372 (PMID: 20726334).","journal-title":"Indian J Exp Biol"},{"issue":"3","key":"242_CR82","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00213-013-3049-1","volume":"228","author":"VT Bonassoli","year":"2013","unstructured":"Bonassoli VT, Contardi EB, Milani H, de Oliveira RM. Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats. Psychopharmacology. 2013;228(3):487\u201398. https:\/\/doi.org\/10.1007\/s00213-013-3049-1.","journal-title":"Psychopharmacology"},{"key":"242_CR83","doi-asserted-by":"publisher","first-page":"PL255","DOI":"10.1016\/0024-3205(92)90119-a","volume":"51","author":"RM Quock","year":"1992","unstructured":"Quock RM, Nguyen E. Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice. Life Sci. 1992;51:PL255\u201360. https:\/\/doi.org\/10.1016\/0024-3205(92)90119-a.","journal-title":"Life Sci"},{"key":"242_CR84","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0091-3057(94)90333-6","volume":"48","author":"PW Caton","year":"1994","unstructured":"Caton PW, Tousman SA, Quock RM. Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze. Pharmacol Biochem Behav. 1994;48:689\u201392. https:\/\/doi.org\/10.1016\/0091-3057(94)90333-6.","journal-title":"Pharmacol Biochem Behav"},{"key":"242_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0091-3057(96)00156-6","volume":"56","author":"CL De Oliveira","year":"1997","unstructured":"De Oliveira CL, Del Bel EA, Guimaraes FS. Effects of l-NOARG on plus maze performance in rats. Pharmacol Biochem Behav. 1997;56:55\u20139. https:\/\/doi.org\/10.1016\/S0091-3057(96)00156-6.","journal-title":"Pharmacol Biochem Behav"},{"key":"242_CR86","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/s0196-9781(01)00439-9","volume":"22","author":"ME Monzon","year":"2001","unstructured":"Monzon ME, Varas MM, De Barioglio SR. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides. 2001;22:1043\u20137. https:\/\/doi.org\/10.1016\/s0196-9781(01)00439-9.","journal-title":"Peptides"},{"key":"242_CR87","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0278-5846(01)00261-5","volume":"26","author":"P Pokk","year":"2002","unstructured":"Pokk P, Vali M. The effects of the nitric oxide synthase inhibitors on the behavior of small-platform-stressed mice in the plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:241\u20137. https:\/\/doi.org\/10.1016\/s0278-5846(01)00261-5.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"242_CR88","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbr.2012.07.037","volume":"235","author":"HY Joung","year":"2012","unstructured":"Joung HY, Jung EY, Kim K, Lee MS, Her S, Shim I. The differential role of NOS inhibitors on stress-induced anxiety and neuroendocrine alterations in the rat. Behav Brain Res. 2012;235(2):176\u201381. https:\/\/doi.org\/10.1016\/j.bbr.2012.07.037.","journal-title":"Behav Brain Res"},{"issue":"3","key":"242_CR89","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pbb.2012.06.004","volume":"102","author":"M Piri","year":"2012","unstructured":"Piri M, Nasehi M, Asgariyan M, Zarrindast MR. Influence of nitric oxide agents in the dorsal hippocampus of mice on anxiogenic-like effect induced by histamine. Pharmacol Biochem Behav. 2012;102(3):391\u20139. https:\/\/doi.org\/10.1016\/j.pbb.2012.06.004.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"242_CR90","doi-asserted-by":"publisher","first-page":"13","DOI":"10.32598\/bcn.9.10.100","volume":"10","author":"E Nikkar","year":"2019","unstructured":"Nikkar E, Ghoshooni H, Hadipour MM, Sahraei H. Effect of nitric oxide on basolateral amygdala on persistence of anxiety and depression in stressed male rats. Basic Clin Neurosci. 2019;10(1):13\u201322. https:\/\/doi.org\/10.32598\/bcn.9.10.100.","journal-title":"Basic Clin Neurosci"},{"key":"242_CR91","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuroscience.2016.01.040","volume":"320","author":"C Vila-Verde","year":"2016","unstructured":"Vila-Verde C, Marinho AL, Lisboa SF, Guimar\u00e3es FS. Nitric oxide in the prelimbic medial prefrontal cortex is involved in the anxiogenic-like effect induced by acute restraint stress in rats. Neuroscience. 2016;320:30\u201342. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.040.","journal-title":"Neuroscience"},{"key":"242_CR92","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pbb.2007.08.008","volume":"88","author":"A Spiacci Jr","year":"2008","unstructured":"Spiacci A Jr, Kanamaru F, Guimar\u00e3es FS, Oliveira RM. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav. 2008;88:247\u201355. https:\/\/doi.org\/10.1016\/j.pbb.2007.08.008.","journal-title":"Pharmacol Biochem Behav"},{"key":"242_CR93","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bcp.2017.11.019","volume":"149","author":"BD Paul","year":"2018","unstructured":"Paul BD, Snyder SH. Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol. 2018;149:101\u20139. https:\/\/doi.org\/10.1016\/j.bcp.2017.11.019.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"242_CR94","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1871527317666180605072018","volume":"17","author":"M Kumar","year":"2018","unstructured":"Kumar M, Sandhir R. Hydrogen sulfide in physiological and pathological mechanisms in brain. CNS Neurol Disord Drug Targets. 2018;17(9):654\u201370. https:\/\/doi.org\/10.2174\/1871527317666180605072018.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"14","key":"242_CR95","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1039\/C8DT04901G","volume":"48","author":"J Park","year":"2019","unstructured":"Park J, Kim T, Kim HJ, Hong J-I. Iridium(iii) complex-based Electrochemiluminescent probe for H2S. Dalton Trans. 2019;48(14):4565\u201373. https:\/\/doi.org\/10.1039\/C8DT04901G.","journal-title":"Dalton Trans"},{"issue":"6","key":"242_CR96","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/bph.12869","volume":"172","author":"EM Bos","year":"2015","unstructured":"Bos EM, van Goor H, Joles JA, Whiteman M, Leuvenink HG. Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol. 2015;172(6):1479\u201393. https:\/\/doi.org\/10.1111\/bph.12869.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"242_CR97","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","volume":"16","author":"K Abe","year":"1996","unstructured":"Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16(3):1066\u201371. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-03-01066.1996.","journal-title":"J Neurosci"},{"issue":"2","key":"242_CR98","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neures.2005.07.002","volume":"53","author":"Y Han","year":"2005","unstructured":"Han Y, Qin J, Chang X, Yang Z, Bu D, Du J. Modulating effect of hydrogen sulfide on gamma-aminobutyric acid B receptor in recurrent febrile seizures in rats. Neurosci Res. 2005;53(2):216\u20139. https:\/\/doi.org\/10.1016\/j.neures.2005.07.002.","journal-title":"Neurosci Res"},{"issue":"1","key":"242_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/ars.2007.1656","volume":"10","author":"MA Garc\u00eda-Bereguia\u00edn","year":"2008","unstructured":"Garc\u00eda-Bereguia\u00edn MA, Samhan-Arias AK, Mart\u00edn-Romero FJ, Guti\u00e9rrez-Merino C. Hydrogen sulfide raises cytosolic calcium in neurons through activation of L-type Ca2+ channels. Antioxid Redox Signal. 2008;10(1):31\u201342. https:\/\/doi.org\/10.1089\/ars.2007.1656.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"242_CR100","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12640-009-9099-9","volume":"17","author":"SM Schreier","year":"2010","unstructured":"Schreier SM, Muellner MK, Steinkellner H, Hermann M, Esterbauer H, Exner M, et al. Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox Res. 2010;17(3):249\u201356. https:\/\/doi.org\/10.1007\/s12640-009-9099-9.","journal-title":"Neurotox Res"},{"issue":"Pt 5","key":"242_CR101","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1042\/BST0351138","volume":"35","author":"L Li","year":"2007","unstructured":"Li L, Moore PK. An overview of the biological significance of endogenous gases: new roles for old molecules. Biochem Soc Trans. 2007;35(Pt 5):1138\u201341. https:\/\/doi.org\/10.1042\/BST0351138.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"242_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/cc7700","volume":"13","author":"F Wagner","year":"2009","unstructured":"Wagner F, Asfar P, Calzia E, Szabo C. Bench-to-bedside review: Hydrogen sulfide\u2014the third gaseous transmitter: applications for critical care. Crit Care (London, England). 2009;13(3):213. https:\/\/doi.org\/10.1186\/cc7700.","journal-title":"Crit Care (London, England)"},{"key":"242_CR103","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.brainres.2010.05.017","volume":"1345","author":"C Ren","year":"2010","unstructured":"Ren C, Du A, Li D, Sui J, Mayhan WG, Zhao H. Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res. 2010;1345:197\u2013205. https:\/\/doi.org\/10.1016\/j.brainres.2010.05.017.","journal-title":"Brain Res"},{"issue":"10","key":"242_CR104","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.108.833491","volume":"120","author":"S Minamishima","year":"2009","unstructured":"Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, et al. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation. 2009;120(10):888\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.833491.","journal-title":"Circulation"},{"issue":"8","key":"242_CR105","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.resuscitation.2011.03.038","volume":"82","author":"J Knapp","year":"2011","unstructured":"Knapp J, Heinzmann A, Schneider A, Padosch SA, B\u00f6ttiger BW, Teschendorf P, et al. Hypothermia and neuroprotection by sulfide after cardiac arrest and cardiopulmonary resuscitation. E Resusc. 2011;82(8):1076\u201380. https:\/\/doi.org\/10.1016\/j.resuscitation.2011.03.038.","journal-title":"E Resusc"},{"key":"242_CR106","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jare.2020.05.007","volume":"27","author":"B Lv","year":"2020","unstructured":"Lv B, Chen S, Tang C, Jin H, Du J, Huang Y. Hydrogen sulfide and vascular regulation\u2014an update. J Adv Res. 2020;27:85\u201397. https:\/\/doi.org\/10.1016\/j.jare.2020.05.007.","journal-title":"J Adv Res"},{"key":"242_CR107","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14737175.2019.1668270","volume":"20","author":"M Chen","year":"2020","unstructured":"Chen M, Pritchard C, Fortune D, Kodi P, Grados M. Hydrogen sulfide: a target to modulate oxidative stress and neuroplasticity for the treatment of pathological anxiety. Expert Rev Neurother. 2020;20:109\u201321. https:\/\/doi.org\/10.1080\/14737175.2019.1668270.","journal-title":"Expert Rev Neurother"},{"key":"242_CR108","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fncel.2017.00375","volume":"11","author":"AV Yakovlev","year":"2017","unstructured":"Yakovlev AV, Kurmasheva ED, Ishchenko Y, Giniatullin R, Sitdikova GF. Age-dependent, subunit specific action of hydrogen sulfide on GluN1\/2A and GluN1\/2B NMDA Receptors. Front Cell Neurosci. 2017;11:375. https:\/\/doi.org\/10.3389\/fncel.2017.00375.","journal-title":"Front Cell Neurosci"},{"key":"242_CR109","doi-asserted-by":"publisher","first-page":"E995","DOI":"10.3390\/biom10070995","volume":"10","author":"O Yakovleva","year":"2020","unstructured":"Yakovleva O, Bogatova K, Mukhtarova R, Yakovlev A, Shakhmatova V, Gerasimova E, et al. Hydrogen sulfide alleviates anxiety, motor, and cognitive dysfunctions in rats with maternal hyperhomocysteinemia via mitigation of oxidative stress. Biomolecules. 2020;10:E995. https:\/\/doi.org\/10.3390\/biom10070995.","journal-title":"Biomolecules"},{"key":"242_CR110","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s42003-019-0431-5","volume":"2","author":"J Yang","year":"2019","unstructured":"Yang J, Minkler P, Grove D, Wang R, Willard B, Dweik R, et al. Non-enzymatic hydrogen sulfide production from cysteine in blood is catalyzed by iron and Vitamin B6. Commun Biol. 2019;2:194. https:\/\/doi.org\/10.1038\/s42003-019-0431-5.","journal-title":"Commun Biol"},{"key":"242_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2017.12.010","volume":"149","author":"KR Olson","year":"2018","unstructured":"Olson KR. H2S and polysulfide metabolism: conventional and unconventional pathways. Biochem Pharmacol. 2018;149:77\u201390. https:\/\/doi.org\/10.1016\/j.bcp.2017.12.010.","journal-title":"Biochem Pharmacol"},{"key":"242_CR112","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.redox.2017.11.009","volume":"15","author":"KR Olson","year":"2018","unstructured":"Olson KR, Gao Y, Arif F, Arora K, Patel S, DeLeon ER, et al. Metabolism of hydrogen sulfide (H2S) and production of reactive sulfur species (RSS) by superoxide dismutase. Redox Biol. 2018;15:74\u201385. https:\/\/doi.org\/10.1016\/j.redox.2017.11.009.","journal-title":"Redox Biol"},{"key":"242_CR113","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/FBP.0b013e3283654258","volume":"24","author":"WL Chen","year":"2013","unstructured":"Chen WL, Xie B, Zhang C, Xu KL, Niu YY, Tang XQ, et al. Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in behavioral models of depression and anxiety. Behav Pharmacol. 2013;24:590\u20137. https:\/\/doi.org\/10.1097\/FBP.0b013e3283654258.","journal-title":"Behav Pharmacol"},{"key":"242_CR114","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2017.01.059","volume":"642","author":"AF Donatti","year":"2017","unstructured":"Donatti AF, Soriano RN, Leite-Panissi CRA, Branco LGD, de Sousa AS. Anxiolytic-like effect of hydrogen sulfide (H2S) in rats exposed and re-exposed to the elevated plus-maze and open field tests. Neurosci Lett. 2017;642:77\u201385. https:\/\/doi.org\/10.1016\/j.neulet.2017.01.059.","journal-title":"Neurosci Lett"},{"key":"242_CR115","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.brainresbull.2020.09.007","volume":"164","author":"E Habibitabar","year":"2020","unstructured":"Habibitabar E, Moridi H, Shateri H, Karimi SA, Salehi I, Komaki A, et al. Chronic NaHS treatment improves spatial and passive avoidance learning and memory and anxiety-like behavior and decreases oxidative stress in rats fed with a high-fat diet. Brain Res Bull. 2020;164:380\u201391. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.09.007.","journal-title":"Brain Res Bull"},{"key":"242_CR116","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/10641963.2014.881838","volume":"37","author":"X Pan","year":"2015","unstructured":"Pan X, Zhang Y, Tao S. Effects of Tai Chi exercise on blood pressure and plasma levels of nitric oxide, carbon monoxide and hydrogen sulfide in real-world patients with essential hypertension. Clin Exp Hypertens. 2015;37:8\u201314. https:\/\/doi.org\/10.3109\/10641963.2014.881838.","journal-title":"Clin Exp Hypertens"},{"key":"242_CR117","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/scisignal.268re2","volume":"2","author":"AK Mustafa","year":"2009","unstructured":"Mustafa AK, Gadalla MM, Snyder SH. Signaling by gasotransmitters. Sci Signal. 2009;2:re2. https:\/\/doi.org\/10.1126\/scisignal.268re2.","journal-title":"Sci Signal"},{"issue":"4","key":"242_CR118","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1006\/meth.1999.0892","volume":"19","author":"VS Sharma","year":"1999","unstructured":"Sharma VS, Magde D. Activation of soluble guanylate cyclase by car-bon monoxide and nitric oxide: a mechanistic model. Methods. 1999;19(4):494\u2013505. https:\/\/doi.org\/10.1006\/meth.1999.0892.","journal-title":"Methods"},{"issue":"26","key":"242_CR119","doi-asserted-by":"publisher","first-page":"20117","DOI":"10.1074\/jbc.M110.116483","volume":"285","author":"L Yi","year":"2010","unstructured":"Yi L, Morgan JT, Ragsdale SW. Identification of a thiol\/disulfide redox switch in the human BK channel that controls its affinity for heme and CO. J Biol Chem. 2010;285(26):20117\u201327. https:\/\/doi.org\/10.1074\/jbc.M110.116483.","journal-title":"J Biol Chem"},{"key":"242_CR120","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-90-481-2259-2_5","volume":"648","author":"SP Brazier","year":"2009","unstructured":"Brazier SP, Telezhkin V, Mears R, M\u00fcller CT, Riccardi D, Kemp PJ. Cysteine residues in the C-terminal tail of the human BK(Ca)alpha subunitare important for channel sensitivity to carbon monoxide. Adv Exp Med Biol. 2009;648:49\u201356. https:\/\/doi.org\/10.1007\/978-90-481-2259-2_5.","journal-title":"Adv Exp Med Biol"},{"key":"242_CR121","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1038\/ncomms5676","volume":"51","author":"S Liang","year":"2014","unstructured":"Liang S, Wang Q, Zhang W, Zhang H, Tan S, Ahmed A, Gu Y. Carbon monoxide inhibits inward rectifier potassium channels in cardiomyocytes. Nat Commun. 2014;51:4676. https:\/\/doi.org\/10.1038\/ncomms5676.","journal-title":"Nat Commun"},{"key":"242_CR122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1039\/9781847555328","volume-title":"Metal-catalysis in industrial organicprocesses","author":"P Maitlis","year":"2006","unstructured":"Maitlis P, Haynes A. Chapter 4 syntheses based on carbon monoxide. In: Chiusoli GP, Maitlis P, editors. Metal-catalysis in industrial organicprocesses. London: The Royal Society of Chemistry; 2006. p. 114\u201362. https:\/\/doi.org\/10.1039\/9781847555328."},{"issue":"6","key":"242_CR123","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.npp.1300132","volume":"28","author":"D Taskiran","year":"2003","unstructured":"Taskiran D, Kutay FZ, Pogun S. Effect of carbon monoxide on dopamine and glutamate uptake and cGMP levels in rat brain. Neuropsychopharmacology. 2003;28(6):1176\u201381. https:\/\/doi.org\/10.1038\/sj.npp.1300132.","journal-title":"Neuropsychopharmacology"},{"key":"242_CR124","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4155\/fmc-2018-0215","volume":"11","author":"W Adach","year":"2019","unstructured":"Adach W, Olas B. Carbon monoxide and its donors\u2014their implications for medicine. Future Med Chem. 2019;11:61\u201373. https:\/\/doi.org\/10.4155\/fmc-2018-0215.","journal-title":"Future Med Chem"},{"key":"242_CR125","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8547364","author":"A Ismailova","year":"2018","unstructured":"Ismailova A, Kuter D, Bohle DS, Butler IS. An overview of the potential therapeutic applications of CO-releasing molecules. Bioinorg Chem Appl. 2018. https:\/\/doi.org\/10.1155\/2018\/8547364.","journal-title":"Bioinorg Chem Appl"},{"key":"242_CR126","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1161\/hh0202.104530","volume":"90","author":"R Motterlini","year":"2020","unstructured":"Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res. 2020;90:E17\u201324. https:\/\/doi.org\/10.1161\/hh0202.104530.","journal-title":"Circ Res"},{"key":"242_CR127","doi-asserted-by":"publisher","first-page":"e5135","DOI":"10.1590\/1414-431x20165135","volume":"49","author":"PG Carvalho-Costa","year":"2016","unstructured":"Carvalho-Costa PG, Branco LG, Leite-Panissi CR. Activation of locus coeruleus heme oxygenase-carbon monoxide pathway promoted an anxiolytic-like effect in rats. Braz J Med Biol Res. 2016;49:e5135. https:\/\/doi.org\/10.1590\/1414-431x20165135.","journal-title":"Braz J Med Biol Res"},{"key":"242_CR128","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1432-1033.1997.00725.x","volume":"247","author":"WK McCoubrey Jr","year":"1997","unstructured":"McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 1997;247:725\u201332. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00725.x.","journal-title":"Eur J Biochem"},{"issue":"20","key":"242_CR129","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2174\/1381612824666180717160623","volume":"24","author":"VB Neis","year":"2018","unstructured":"Neis VB, Rosa PB, Moretti M, Rodrigues ALS. Involvement of heme oxygenase-1 in neuropsychiatric and neurodegenerative diseases. Curr Pharm Des. 2018;24(20):2283\u2013302. https:\/\/doi.org\/10.2174\/1381612824666180717160623.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"242_CR130","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0306-4522(94)90018-3","volume":"63","author":"SR Vincent","year":"1994","unstructured":"Vincent SR, Das S, Maines MD. Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience. 1994;63(1):223\u201331. https:\/\/doi.org\/10.1016\/0306-4522(94)90018-3.","journal-title":"Neuroscience"},{"issue":"5093","key":"242_CR131","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.7678352","volume":"259","author":"A Verma","year":"1993","unstructured":"Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993;259(5093):381\u20134. https:\/\/doi.org\/10.1126\/science.7678352.","journal-title":"Science"},{"key":"242_CR132","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1523\/JNEUROSCI.16-04-01389.1996","volume":"16","author":"J Pineda","year":"1996","unstructured":"Pineda J, Kogan JH, Aghajanian GK. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J Neurosci. 1996;16:1389\u201399. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-04-01389.1996.","journal-title":"J Neurosci"},{"key":"242_CR133","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbr.2017.09.007","volume":"336","author":"RA Cazuza","year":"2018","unstructured":"Cazuza RA, Pol O, Ramos C, Leite-Panissi A. Enhanced expression of heme oxygenase-1 in the locus coeruleus can be associated with anxiolytic-like effects. Behav Brain Res. 2018;336:204\u201310. https:\/\/doi.org\/10.1016\/j.bbr.2017.09.007.","journal-title":"Behav Brain Res"},{"key":"242_CR134","doi-asserted-by":"publisher","first-page":"104842","DOI":"10.1016\/j.neuint.2020.104842","volume":"140","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang L-M, Zhang D-X, Zheng W-C, Bai Y, et al. CORM-3 ameliorates neurodegeneration in the amygdala and improves depression- and anxiety-like behavior in a rat model of combined traumatic brain injury and hemorrhagic shock. Neurochem Int. 2020;140:104842. https:\/\/doi.org\/10.1016\/j.neuint.2020.104842.","journal-title":"Neurochem Int"},{"issue":"21","key":"242_CR135","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.3760\/cma.j.issn.0366-6999.20133031","volume":"127","author":"H Tian","year":"2014","unstructured":"Tian H. Advances in the study on endogenous sulfur dioxide in the cardiovascular system. Chin Med J. 2014;127(21):3803\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20133031.","journal-title":"Chin Med J"},{"key":"242_CR136","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0227","author":"E Ghasemi","year":"2020","unstructured":"Ghasemi E, Afkhami Aghda F, Rezvani ME, Shahrokhi Raeini A, Hafizibarjin Z, Zare MF. Effect of endogenous sulfur dioxide on spatial learning and memory and hippocampal damages in the experimental model of chronic cerebral hypoperfusion. J Basic Clin Physiol Pharmacol. 2020. https:\/\/doi.org\/10.1515\/jbcpp-2019-0227.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"242_CR137","doi-asserted-by":"publisher","first-page":"108252","DOI":"10.1016\/j.neuropharm.2020.108252","volume":"176","author":"X Shi","year":"2020","unstructured":"Shi X, Gao Y, Song L, Zhao P, Zhang Y, Ding Y, et al. Sulfur dioxide derivatives produce antidepressant- and anxiolytic-like effects in mice. Neuropharmacology. 2020;176:108252. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108252.","journal-title":"Neuropharmacology"},{"key":"242_CR138","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.mie.2014.11.025","volume":"555","author":"PK Kamat","year":"2015","unstructured":"Kamat PK, Kalani A, Tyagi N. Role of hydrogen sulfide in brain synaptic remodeling. Methods Enzymol. 2015;555:207\u201329.","journal-title":"Methods Enzymol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43440-021-00242-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:54:41Z","timestamp":1616738081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43440-021-00242-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00242-2","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}